Longeveron welcomes Dr. George Paletta to its Board of Directors

– USA, FL –  Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions, announced the election of Dr.